Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection

Rheumatology (Oxford). 2021 Jan 5;60(1):479-480. doi: 10.1093/rheumatology/keaa689.

Authors

Hannah M Schenker¹, Melanie Hagen¹, David Simon¹, Georg Schett¹, Bernhard Manger¹

Affiliation

¹ Department of Internal Medicine 3 - Rheumatology and Immunology, University Hospital of Erlangen-Nuremberg, Erlangen, Germany.

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Viral / immunology*
Arthritis, Reactive / diagnosis
Arthritis, Reactive / drug therapy
Arthritis, Reactive / immunology*
C-Reactive Protein / immunology
COVID-19 / immunology*
COVID-19 Serological Testing
Female
Glucocorticoids / therapeutic use
Humans
Immunoglobulin G / immunology*
Knee Joint
Leg Dermatoses / immunology
Prednisolone / therapeutic use
Purpura / immunology
SARS-CoV-2 / immunology*
Skin Diseases, Vascular / diagnosis
Skin Diseases, Vascular / drug therapy
Skin Diseases, Vascular / immunology*
Vasculitis / diagnosis
Vasculitis / drug therapy
Vasculitis / immunology*

Substances

Antibodies, Viral
Glucocorticoids
Immunoglobulin G
C-Reactive Protein
Prednisolone